Navigation Links
Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis

fection with Gram-negative bacteria, particularly pulmonary P. aeruginosa, represents the single greatest cause of morbidity and mortality among CF patients. Currently there is no known cure for CF, and the goal of CF therapy is to control symptoms and prevent further lung damage.

About Gilead Sciences

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. For more information on Gilead Sciences, please visit the company's website at www.gilead.com or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

This press release includes forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that are subject to risks, uncertainties and other factors. For example, the safety and efficacy data from additional clinical studies may not warrant further development of this compound and initiating and completing clinical trials may take longer or cost more than expected. In addition, future discussions with the FDA may impact the amount of data needed and timelines for review, which may differ materially from Gilead's current projections. Further, the FDA may not approve aztreonam lysine for inhalation for the treatment of CF in the United States, and any marketing approval, if granted, may have significant limitations on its use. If and when regulatory approval is obtained, we will rely on PARI to distribute the device through specialty pharmacies or other distribution channels. If sufficient quantities of this device are not available at the time of a commercial launch or following such a launch, the commercial launch of aztreonam lysine for inhalation could be delayed, and the anticipated contribut
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
5. Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
6. Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219 to be Presented at AACR
7. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:9/19/2014)... VIENNA , Sept. 19, 2014 ... positive interim clinical data for its lead candidate ITCA ... diabetes patients with high baseline HbA1c levels at the ... for the Study of Diabetes (EASD). Data from the ... reduced levels of blood sugar in patients with poorly ...
(Date:9/19/2014)... , September 19, 2014 Reductions ... for many years in people with diabetes type 2 ... long term benefits for the kidneys." Australian ... with type 2 diabetes leads to persistent reductions in ... The global study has found that, five ...
(Date:9/18/2014)... Sept. 18, 2014  Low T Center endorses ... in Hyattsville, Maryland earlier ... the proper patient population for testosterone therapy (TRT), ... associated with TRT. Examining recent claims from studies that ... "available epidemiological studies do not provide convincing evidence ...
Breaking Medicine Technology:Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2
... strengths of two institutions separated by nearly 9,000 miles over ... fight against cancer - the United States Agency for International ... Research Center to aid in the construction of the first ... is the first true collaboration between an African and a ...
... Oct. 26 Reportlinker.com announces that a new ... , Reportlinker Adds Outsourcing Preclinical Studies ... http://www.reportlinker.com/p0156558/Reportlinker-Adds-Outsourcing-Preclinical-Studies-to-China.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , Within the past ... well as private and joint venture CRO,s have ...
Cached Medicine Technology:Hutchinson Center to Build First U.S. Cancer Clinic and Training Facility in Africa Thanks, in Part, to a Grant From USAID 2Hutchinson Center to Build First U.S. Cancer Clinic and Training Facility in Africa Thanks, in Part, to a Grant From USAID 3Hutchinson Center to Build First U.S. Cancer Clinic and Training Facility in Africa Thanks, in Part, to a Grant From USAID 4Hutchinson Center to Build First U.S. Cancer Clinic and Training Facility in Africa Thanks, in Part, to a Grant From USAID 5Hutchinson Center to Build First U.S. Cancer Clinic and Training Facility in Africa Thanks, in Part, to a Grant From USAID 6Reportlinker Adds Outsourcing Preclinical Studies to China 2Reportlinker Adds Outsourcing Preclinical Studies to China 3Reportlinker Adds Outsourcing Preclinical Studies to China 4Reportlinker Adds Outsourcing Preclinical Studies to China 5Reportlinker Adds Outsourcing Preclinical Studies to China 6
(Date:9/21/2014)... An experienced review website in the global market, ... and announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and ... There has been a boom in websites in recent ... increase in the number of web hosting companies that ... prices. VPS (Virtual Private Server) is the method of ...
(Date:9/21/2014)... BambooIndustry.com, an experienced producer of natural bamboo items, has ... http://www.bambooindustry.com/products/bamboo-panel/ ). The company’s excellent panels are very popular ... discounted prices now, from 10 to 30 percent off. ... are available in many specifications; they are promised to ... finely manufactured by qualified workers. They are specially offered ...
(Date:9/21/2014)... September 21, 2014 Faculty and staff at ... coed preschool in Owings Mills, Md., kicked off the academic ... Vivofit bands. GFS is the first independent school to receive ... burned and even sleep patterns— as part of a pilot ... running and walking specialty chain. The Vivofit bands are just ...
(Date:9/21/2014)... According to latest National Vital Statistics Reports ... (10.5 births per 1,000 women in 2013). Since 2000, the ... by 2 percent per year. The birth rate for women ... over) also rose, the first such increase since 2008. Ultimately ... as many first births to women aged 35 and older ...
(Date:9/20/2014)... 21, 2014 Recently, iFitDress.com, a well-known wedding ... beautiful party dresses . In addition, the company has ... aim of the promotion is to benefit all of its ... its online store now. , Along with beautiful party ... items. It has recently released its new sexy short prom ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2Health News:Garrison Forest School Leader in Independent School Wellness Programs 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 3Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 4Health News:Beautiful Party Dresses For Autumn Unveiled By iFitDress.com 2
... college athletes who are on low-calorie diets could be ... Louis University research which was published in this month’s ... ,Researchers studied risk factors for exercise-related leg pain, including ... sports – cross-country running, field hockey, soccer and volleyball. ...
... teenage suicide and the antidepressant drug usage has been debatable. ... in kids and teens in most of the clinical trials ... ,In a recent study published in the September issue ... the Department of Psychiatry at Drexel University College of Medicine ...
... measures the amounts of two members of the same protein ... oncogene // , and the other as a tumor suppressor ... benefit from chemotherapy and those who won’t, according to researchers. ... and studies have shown that it can predict the aggressiveness ...
... nephrologists don't feel well prepared to make the decision ... end of life // , reports a study in ... Nephrology. ,Nephrologists who are more experienced and more ... by the Renal Physicians Association and the American Society ...
... Researchers said that a pill containing rhubarb extract could ... ,Researchers studied 109 perimenopausal women to determine ... women 4 milligrams of the extract, while the other ... which took the rhubarb extract pill, had less severe ...
... linked to increased incomes. Researchers said this demonstrated the ... social capital," said co-author Edward Stringham, an economics professor ... out networking, building relationships, and adding contacts to their ... said that the findings would be published in the ...
Cached Medicine News:Health News:Female Athletes at Risk of Stress Fractures 2Health News:Female Athletes at Risk of Stress Fractures 3Health News:Test Helps Identify Patients with Breast Cancer 2Health News:Many Kidney Specialists Feel Unprepared for End-of-Life Decisions 2
Clerz Plus helps retain moisture to relieve dryness and removes protein buildup from your lenses while you wear them for longer wear comfort....
Lens Plus rewetting drops for soft contact lenses....
... free lubricating and rewetting drops ... while you're wearing soft contact ... formula is ideal for eyes ... preservatives and for frequent users ...
... Renu Multiplus No Rub formula is the ... today. All steps in one bottle without ... stores soft contact lenses and removes protein ... multi-purpose solution that contains Hydranate, a special ...
Medicine Products: